These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression. Larghero P; Venè R; Minghelli S; Travaini G; Morini M; Ferrari N; Pfeffer U; Noonan DM; Albini A; Benelli R Carcinogenesis; 2007 May; 28(5):1008-20. PubMed ID: 17127716 [TBL] [Abstract][Full Text] [Related]
33. N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. Cai T; Fassina G; Morini M; Aluigi MG; Masiello L; Fontanini G; D'Agostini F; De Flora S; Noonan DM; Albini A Lab Invest; 1999 Sep; 79(9):1151-9. PubMed ID: 10496534 [TBL] [Abstract][Full Text] [Related]
34. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]
35. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells. Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650 [TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519 [TBL] [Abstract][Full Text] [Related]
37. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568 [TBL] [Abstract][Full Text] [Related]
38. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma. Lane BR; Liu J; Bock PJ; Schols D; Coffey MJ; Strieter RM; Polverini PJ; Markovitz DM J Virol; 2002 Nov; 76(22):11570-83. PubMed ID: 12388718 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]